KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Range Low Price High Price Comment
30 days $8.70 $12.25 Thursday, 25th Apr 2024 CNTA stock ended at $8.93. This is 5.60% less than the trading day before Wednesday, 24th Apr 2024. During the day the stock fluctuated 5.47% from a day low at $8.90 to a day high of $9.39.
90 days $7.38 $12.41
52 weeks $3.96 $12.41

Historical Centessa Pharmaceuticals Limited prices

Date Open High Low Close Volume
Apr 25, 2024 $9.26 $9.39 $8.90 $8.93 286 149
Apr 24, 2024 $9.42 $9.52 $8.70 $9.46 2 246 262
Apr 23, 2024 $10.00 $10.17 $9.37 $9.40 173 152
Apr 22, 2024 $10.90 $10.90 $9.70 $10.00 209 749
Apr 19, 2024 $10.37 $10.66 $10.26 $10.57 148 731
Apr 18, 2024 $10.68 $10.84 $10.37 $10.53 107 693
Apr 17, 2024 $11.14 $11.25 $10.75 $10.78 112 635
Apr 16, 2024 $10.66 $11.31 $10.53 $11.03 171 754
Apr 15, 2024 $11.34 $11.38 $10.73 $10.78 71 019
Apr 12, 2024 $11.97 $11.97 $10.96 $11.32 185 615
Apr 11, 2024 $11.20 $12.25 $10.93 $11.87 152 944
Apr 10, 2024 $10.84 $11.22 $10.84 $11.15 88 014
Apr 09, 2024 $10.80 $11.33 $10.80 $11.31 114 269
Apr 08, 2024 $10.75 $10.85 $10.20 $10.75 68 745
Apr 05, 2024 $10.28 $10.76 $10.06 $10.75 132 814
Apr 04, 2024 $10.94 $11.01 $10.05 $10.37 101 417
Apr 03, 2024 $11.29 $11.29 $10.58 $10.82 174 419
Apr 02, 2024 $10.92 $11.37 $10.59 $11.33 170 122
Apr 01, 2024 $11.47 $11.48 $10.56 $11.08 244 661
Mar 28, 2024 $11.06 $11.47 $10.82 $11.30 172 148
Mar 27, 2024 $10.76 $11.23 $10.39 $11.10 68 505
Mar 26, 2024 $11.58 $11.80 $10.71 $10.76 104 695
Mar 25, 2024 $12.20 $12.40 $11.06 $11.51 446 453
Mar 22, 2024 $12.16 $12.40 $11.89 $12.20 160 988
Mar 21, 2024 $11.88 $12.41 $11.85 $12.08 258 281
Click to get the best stock tips daily for free!

About Centessa Pharmaceuticals Limited

Centessa Pharmaceuticals Limited Centessa Pharmaceuticals plc, a clinical-stage pharmaceutical company, discovers, develops, and delivers medicines to patients. Its registrational pipeline products include Lixivaptan, a vasopressin V2 receptor small molecule inhibitor that is in Phase III clinical development for the treatment of autosomal dominant polycystic kidney disease; and SerpinPC, an activated protein C inhibitor, which is in Phase IIa clinical development for the treatm... CNTA Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT